Biologic Drugs With Mechanism of Action: Programmed Death Ligand-1-directed Antibody Interactions
✉ Email this page to a colleague
Biologic Drugs With Mechanism of Action: Programmed Death Ligand-1-directed Antibody Interactions
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Emd Serono, Inc. | BAVENCIO | avelumab | Injection | 761049 | 2017-03-23 | ⤷ Get Started Free | ⤷ Get Started Free |
| Astrazeneca Uk Ltd | IMFINZI | durvalumab | Injection | 761069 | 2017-05-01 | ⤷ Get Started Free | ⤷ Get Started Free |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |
